Researchers Provide New Insights Into Adult Rhinosinusitis

Article

Acute bacterial rhinosinusitis in adults is a common malady, with between 30 million to 35 million cases a year. These patients are seen by a range of practitioners, from primary care physicians to otolaryngologists. Findings from a meta-analysis that examined the use of antibiotics for treatment of these patients, Systematic Review of Antimicrobials for Acute Rhinosinusitis by authors Michael C. Singer, MD, Richard M Rosenfeld, MD, MPH, and Stacie Schilling Jones, MPH, were presented at the 2007 American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) annual meeting today.

Researchers noted several interesting points revealed in their research, including that the natural course of acute rhinosinusitis in adults is more prolonged than traditionally thought. Only a small minority of patients is cured or report improvement after three to five days, even when treated with an antibiotic. A second finding showed that antibiotics do provide a benefit in regard to the number of patients improved or cured, but only seven to 12 days after initiation of treatment with antibiotics. Before seven days, antibiotics do not provide a significant advantage, compared to treating simply with a placebo. An additional finding is the significant frequency at which negative side effects, such as gastrointestinal upset and diarrhea, occur with antibiotic treatment.

Findings from the study may help to determine a natural history of acute rhinosinusitis in adults, and what to expect when antimicrobial therapy is administered.

Source: American Academy of Otolaryngology Head and Neck Surgery

Recent Videos
Annet Adegboyega, DNP, MSN, BSN, RN, CNOR; Mihyun "Rose" Jang, MSN, MPH, BSN, RN, CNOR; and Renilda Tijones, MSN, BSN, RN, CNOR.
Paulo J. M. Brois, DVM, MSN, RN; Luisa M. P. Soares, RN; and Teresa A. Santos, RN, at #AORN2025
Michael Sinnott, MBBS, FACEM, FRACP, at 2025 AORN Global Conference & Expo.
Meet Marjorie Wall, EDBA, CRCST, CIS, CHL, CSSBB.
A veterinarian in a protective suit takes tests on animals on a farm.   (Adobe Stock 829620654 by Яна Ерік Татевосян)
David Angulo, MD, President and Chief Executive Officer, Fungal Disease Expert
•	Rebecca (Bartles) Crapanzano-Sigafoos, DrPH, MPH, CIC, FAPIC (corresponding author), executive director of APIC’s Center for Research, Practice, and Innovation, and lead author of the study.
Meet Jenny Hayes, MSN, RN, CIC, CAIP, CASSPT.
Meet Shannon Simmons, DHSc, MPH, CIC.
Related Content